Sarissa Capital Management established a new position in Biohaven Ltd. (NYSE:BHVN) during the fourth quarter, acquiring 513,184 shares worth $5.79 million at quarter’s end, according to a February 17, ...
Shareholders in Alkermes have quelled a challenge from Sarissa Capital, reelecting seven board members and rejecting three nominees from the activist investor, the Ireland-based drugmaker said. Early ...
NEW YORK, June 13 (Reuters) - Activist investor Sarissa Capital may have cleared a stumbling block in its push for board seats at Alkermes when one of its candidates resigned from the board of a ...
Sarissa Capital urges Alkermes shareholders to vote for its board nominees after years of rejections
After overhauling Amarin’s board earlier this year, activist investor Sarissa Capital has set its sights on Alkermes. In a new letter to shareholders, the group is pressing Alkermes investors to vote ...
(Reuters) - U.S. respiratory drug company Innoviva Inc has reached a settlement with activist hedge fund Sarissa Capital Management LP to replace its board of directors and remove the threat of a new ...
Sarissa believes Amarin leadership will continue to destroy shareholder value during this critical period; We cannot afford to maintain the status quo Sarissa has a stellar track record of success and ...
GREENWICH, Conn.--(BUSINESS WIRE)-- Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN): Sarissa believes Amarin’s stock is ...
Ariad Pharmaceuticals Chief Executive Officer Harvey Berger will retire this year in a settlement with activist hedge fund Sarissa Capital, capping months of agitation against the cancer drug maker.
GREENWICH, Conn.--(BUSINESS WIRE)--Sarissa Capital Management LP (“Sarissa”) today made the following statement regarding its ongoing discussions with Amarin Corporation plc (NASDAQ: AMRN) regarding ...
On Tuesday, Sarissa Capital Management, an activist investment firm focusing on the pharmaceutical sector, put pressure on Amarin (US:AMRN) to hold a special meeting to straighten out its board issues ...
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Feb 12 (Reuters) - U.S. respiratory drug company Innoviva Inc has reached a settlement with activist hedge fund Sarissa Capital Management LP to replace its board of directors and remove the threat of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results